# Adaptive Neoadjuvant Therapy for Esophageal Cancer

> **NCT06990178** · NA · ENROLLING_BY_INVITATION · sponsor: **Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center** · enrollment: 43 (estimated)

## Conditions studied

- Esophageal Carcinoma
- Neoadjuvant Therapy

## Interventions

- **RADIATION:** Neoadjuvant concurrent chemoradiotherapy

## Key facts

- **NCT ID:** NCT06990178
- **Lead sponsor:** Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2028-03-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990178, "Adaptive Neoadjuvant Therapy for Esophageal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06990178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*